Pai-2 Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2002-04-26 and was issued with the 100344894 ACN. Its Australian Business Number is 69100344894. Since 2008-09-30, the company is headquartered in NSW, post code 2126. The previous headquarters were located in NSW 2120 (from 2002-07-01 to 2008-09-30). Pai-2 Pty Ltd was registered for the GST on 2002-07-01. Pai-2 Pty Ltd has been using the Pai-2 Pty Limited trading name since 2002-07-01 (it has to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The above data comes from the ABN database which was updated on 2010-12-22.
| Status | From | To |
|---|---|---|
| Active | 2002-07-01 | current |
| Name | From | To |
|---|---|---|
| Pai-2 Pty Ltd | 2002-07-01 | current |
| Name | From | To |
|---|---|---|
| Pai-2 Pty Limited | 2002-07-01 | current |
| Location | From | To |
|---|---|---|
| NSW 2126 | 2008-09-30 | current |
| NSW 2120 | 2002-07-01 | 2008-09-30 |
| Status | From | To |
|---|---|---|
| Registered | 2002-07-01 | current |
Advertisements
General information:
| Patent status: |
Ceased The granted patent was not renewed. |
| Patent type: | STANDARD |
International Patent Classification:
| IPC Mark: | A61K 38/57 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l) |
| Main group code: | 38 - medicinal preparations containing peptides (peptides containing beta-lactam rings a61k0031000000; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, a61k0031000000; ergoline-based peptides a61k0031480000; containing macromolecular compounds having statistically distributed amino acid units a61k0031740000; medicinal preparations containing antigens or antibodies a61k0039000000; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, a61k0047000000) |
| Subgroup code: | 57 - from animals; from humans |
IP Australia process information:
| Expiry date: | 2018-11-13 |
International Patent Classification:
| IPC Mark: | C07K 14/47 |
| Section code: | C - chemistrymetallurgy |
| Class code: | 7 - organic chemistry |
| Subclass code: | K - peptides (peptides containing -lactam rings c07d; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d; ergot alkaloids of the cyclic peptide type c07d0519020000; genetic engineering processes for obtaining peptides c12n0015000000) |
| Main group code: | 14 - peptides having more than 20 amino acids; gastrins; somatostatins; melanotropins; derivatives thereof |
| Subgroup code: | 47 - from mammals |
IP Australia process information:
| Expiry date: | 2021-02-23 |
General information:
| Patent status: |
Lapsed Either the application has not been accepted by 21 months after the first examination report (or 12 months after the Raising the Bar Act) or some other deadline in the prosecution process has not been completed in time, for example IP Australia has issued a direction to file a request for examination and the applicant has not done so in the required period (2 months). |
| Patent type: | STANDARD |
International Patent Classification:
| IPC Mark: | C07K 14/81 |
| Section code: | C - chemistrymetallurgy |
| Class code: | 7 - organic chemistry |
| Subclass code: | K - peptides (peptides containing -lactam rings c07d; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d; ergot alkaloids of the cyclic peptide type c07d0519020000; genetic engineering processes for obtaining peptides c12n0015000000) |
| Main group code: | 14 - peptides having more than 20 amino acids; gastrins; somatostatins; melanotropins; derivatives thereof |
| Subgroup code: | 81 - protease inhibitors |
IP Australia process information:
| Expiry date: | 2021-02-23 |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.